Delivery Order SPE2DB22D9304-SPE2DB25FSTC9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $61,902.91 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. This firm fixed-price delivery order was awarded on July 14, 2025, with an ultimate completion date of August 4, 2025, and represents no set-aside designation. The award falls under DMS Pharmaceutical Group's existing single-award Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $61,902.91 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. The award, issued on July 25, 2025, with an ultimate completion date of August 15, 2025, operates under a firm fixed-price contract type with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a $61,538.77 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for MACI 3cm x 5cm implant sheets. The contract, issued on September 4, 2025, with an ultimate completion date of September 25, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $61,902.91 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. The contract is a firm fixed-price delivery order with an ultimate completion date of September 8, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA's SPE2DB...
- The Defense Logistics Agency awarded a delivery order valued at $61,902.91 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. The contract is a firm fixed-price delivery order with an ultimate completion date of August 28, 2025, and was awarded on August 7, 2025. This award utilizes no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open market...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $61,902.91 to DMS Pharmaceutical Group Inc. for MACI 3cm x 5cm implant sheets. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. The delivery order was issued on July 18, 2025, with an ultimate completion date of August 8, 2025, and no set-aside designation was used in this procurement...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $61,902.91 for MACI 3cm x 5cm implant sheets. The contract, issued on June 26, 2025, with an ultimate completion date of July 18, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $61,538.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. This firm fixed-price delivery order was awarded on September 10, 2025, with an ultimate completion date of October 1, 2025, and carries no set-aside designation. The contract represents a discrete order issued under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a $61,902.91 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on April 24, 2025, for MACI 3cm x 5cm implant sheets, with an ultimate completion date of May 15, 2025. This delivery order carries no set-aside designation and will be performed in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois, serves as the prime contractor and will supply these medical implant...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for MACI 3cm x 5cm implant sheets valued at $61,538.77. This firm fixed-price delivery order, issued on September 15, 2025, is expected to be completed by October 6, 2025. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly within the open market while leveraging its small...
- SPE2DB22D9304Indefinite Delivery Contract
- SPE2DB22D9304-SPE2DB25FSTC9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $61,538.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. This firm fixed-price delivery order, issued on September 25, 2025, with an ultimate completion date of October 17, 2025, carries no set-aside designation. The award represents a task order executed under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities. DMS Pharmaceutical Group's established position as a critical supplier within the federal pharmaceutical supply chain, demonstrated through its extensive portfolio of prior awards covering prescription medications, biologics, and specialized medical consumables, positions the company to fulfill this specific delivery requirement efficiently. The company's capabilities in pharmaceutical product distribution directly support the Defense Logistics Agency's mission to provision medical supplies across military health facilities nationwide, with this particular order supporting the specialized implant supply needs of federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $61.5k | 9/25/25 |